Women’s Health Diagnostics Market Size, Share, Forecast | Industry Forecast
The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.
(firmenpresse) - The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.
Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market.
Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centres are also expected to play a major role in market growth.
However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market.
Download PDF Brochure https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901
Women’s health diagnostics market segmentation:
•Basis of application
•Basis of end user
•Basis of region
The Major Players Opearting in the Women’s health diagnostics market:
Major players in the global women’s health diagnostics market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).
The Major Players Opearting in the Women’s health diagnostics market:
The global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded the largest share of the global women health diagnostics market. The major share of this region can be attributed to increasing prevalence of cancer among women in this region, increasing incidence of lifestyle related health disorders, growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and increasing demand for fertility testing monitors.
Read More in Detailed (Women’s health diagnostics market): https://www.marketsandmarkets.com/PressReleases/womens-health-diagnostics.asp
Themen in dieser Pressemitteilung:
women-s-health-diagnostics-market
marketsandmarkets
syndrome
hpv
fertility-test
pregnancy-test
urinary-tract-infections
osteoporosis
breast
cervical-and-ovarian-cancer
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals.
MarketsandMarkets™ Research Private Ltd.
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+1-888-600-6441
sales(at)marketsandmarkets.com
MarketsandMarkets™ Research Private Ltd.
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+1-888-600-6441
sales(at)marketsandmarkets.com
Datum: 09.07.2019 - 11:22 Uhr
Sprache: Deutsch
News-ID 595465
Anzahl Zeichen: 2590
contact information:
Contact person: Rama Sharma
Town:
Pune
Phone: +1-888-600-6441
Kategorie:
Healthcare & Medical
Typ of Press Release: Financial
type of sending: send
Diese Pressemitteilung wurde bisher 264 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Women’s Health Diagnostics Market Size, Share, Forecast | Industry Forecast"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
